University of Sydney is offering postgraduate funding for Seasonal Flu Vaccine Development Project. Australian and New Zealand citizens can apply for this application . The sponsorship will be valued at the same rate as the Australian Postgraduate Award, and will be indexed annually. It may be renewed for up to three years, subject to satisfactory progress. The application deadline is 29 August 2014.
Study Subject(s): award is awarded for Seasonal Flu Vaccine Development Project.
Course Level: award is available for undertaking postgraduate research project at University of Sydney.
Programme Provider: University of Sydney, Australia
Award can be taken at: Australia
Accreditation: University of Sydney is an accredited university. University of Sydney is accredited by the Group of Eight, APRU, ASAIHL and WUN.
Eligibility: Applicants should have an interest in biotechnology and biophysics and experience in hands on laboratory work using biophysical methods such as light scattering and fluorescence spectroscopy, electron and optical microscopy, chromatographic methods such as SEC-HPLC, and being able to use data analysis software such as MATLAB or Igor Pro would be an added benefit. We seek a candidate who is independent and self-motivated, yet still able to work as part of a team. The candidate should be able to demonstrate very strong interpersonal and communication skills. Applicants must be Australian citizens, Australian permanent residents or New Zealand citizens.
Open for International Students: Australian citizens, Australian permanent residents or New Zealand citizens can apply for this postgraduate scholarship.
Description: A full-time postgraduate scholarship is available to start immediately for a suitably qualified candidate with a good honours or masters degree in an interdisciplinary field, such as chemistry, biochemistry, physical chemistry, chemical engineering, pharmaceutical science or material science, is required to undertake research studies leading to a PhD in Pharmacy. The project is highly interdisciplinary, involving the use of numerous biophysical methods in order to understand and therein gain insight to enhance the stability of seasonal flu vaccine. In addition, it requires working on the development of novel approaches to study different aspects of the vaccine with an emphasis on degradation issues during processing steps. The research will span both fundamental, applied research and process development on a broad range of characterization, formulation and degradation issues including but not limited to study – overall stability of the vaccine and structure of the virus, protein aggregation, particle size, surfactant-virus interaction, degradation mechanism of the virus by surfactants and temperature, and finding appropriate stabilizers. The candidate will have a rare opportunity to work in an academic environment, which collaborates closely with the world’s leading vaccine manufacturer with an aim to streamline vaccine manufacturing.
Number of award(s): One postgraduate support will be available.
Duration of award(s): award is offered for up to three years. It may be renewed for up to three years, subject to satisfactory progress.
What does it cover? The sponsorship will be valued at the same rate as the Australian Postgraduate Award and will be indexed annually.
Selection Criteria: Not Known
Notification: Not Known
How to Apply: Applications should be emailed directly to Dr. V. Kayser at veysel.kayser-at-sydney.edu.au and should include a CV, a copy of an academic transcript(s) and the names and contact details of at least two referees.
Application Deadline: The application deadline is 29 August 2014.